First reported case of Omenn syndrome in a patient with reticular dysgenesis - 30/03/13
Doi : 10.1016/j.jaci.2012.07.045
Lauren A. Henderson, MD a, Francesco Frugoni, PhD a, Gregory Hopkins, BS b, Waleed Al-Herz, MD c, Katja Weinacht, MD b, d, Anne Marie Comeau, PhD e, Francisco A. Bonilla, MD, PhD a, Luigi D. Notarangelo, MD a, f, Sung-Yun Pai, MD b, d 
a Division of Immunology, Children’s Hospital, Boston, Mass
b Division of Hematology and Oncology, Children’s Hospital, Boston, Mass
f Manton Center for Orphan Disease Research, Children’s Hospital, Boston, Mass
c Pediatric Department, Faculty of Medicine, Allergy and Clinical Immunology Unit, Kuwait University, Kuwait City, Kuwait
d Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Mass
e New England Newborn Screening Program, University of Massachusetts Medical School, Worcester, Mass
| This work was partly supported by a Translational Investigator Service Award (to S.-Y.P.), the Manton Foundation (a grant to L.D.N), the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grant no. U54AI082973 to S.-Y.P. and L.D.N.), the Centers for Disease Control and Prevention (grant no. 1U01EH00362 to A.M.C.), and the Kuwait Foundation for Advancement of Sciences (grant no. 2010-1302-05 to W.A.-H.) |
|
| Disclosure of potential conflict of interest: F. A. Bonilla is a Board member for Green Cross; has consultancy arrangements with the Immune Deficiency Foundation, Springleaf Pharmaceuticals, and CSL Behring; has received one or more payments for lecturing from Baxter Healthcare Corporation; and has received royalties from UpToDate in Medicine. A. M. Comeau has been supported by one or more grants from and has received support for travel from the Centers for Disease Control and Prevention; has consultancy arrangements with Duke and ACMG; and is employed by the University of Massachusetts Medical School. L. A. Henderson is employed by Children’s Hospital Boston and has received one or more payments for travel/accommodations/meeting expenses from the Childhood Arthritis & Rheumatology Research Alliance. L. D. Notarangelo has received one or more grants from the National Institute of Allergy and Infectious Diseases/National Institutes of Health (grant no. U54-AI082973) and from the Manton Foundation; is a Board member for the Immune Disease Institute and for the Center for Chronic Immunodeficiencies, Freiburg (Germany); has received one or more grants from or has one or more grants pending with the March of Dimes; has received payments for lecturing and for travel/accommodations/meeting expenses from various institutions (nationally and internationally); and has received royalties from UpToDate. S.-Y. Pai has been supported by one or more grants from Boston Children’s Hospital’s Translational Investigator Service, funded in part by the Venture Philanthropy Network. |
© 2012
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 4
P. 1227 - avril 2013 Retour au numéro
Article précédent
- Spiking venom with rVes v 5 improves sensitivity of IgE detection in patients with allergy to Vespula venom
- Byrthe Vos, Julian Köhler, Sabine Müller, Eva Stretz, Franziska Ruëff, Thilo Jakob
- Persistence of natural killer cells with expansion of a hypofunctional CD56−CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3–deficient severe combined immunodeficiency
- Laure Farnault, Hervé Chambost, Gérard Michel, Isabelle Thuret, Geneviève de Saint Basile, Alain Fischer, Capucine Picard, Christophe Picard, Florence Orlanducci, Catherine Farnarier, Alessandro Moretta, Daniel Olive
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?